Zobrazeno 11 - 20
of 39
pro vyhledávání: '"59"'
Autor:
Jana Drozenova, Jitka Moravcova, Jaromír Astl, Petr Hrabal, Barbora Pekova, Eliska Vaclavikova, Miloš Taudy, Petr Lastuvka, Rami Katra, Bela Bendlova, Martin Chovanec, Daniela Kodetova, Vlasta Sykorova, Josef Vcelak, Petr Vlcek, Karolina Mastnikova, Petr Bavor
Publikováno v:
Cancers
Volume 13
Issue 8
Cancers, Vol 13, Iss 1932, p 1932 (2021)
Volume 13
Issue 8
Cancers, Vol 13, Iss 1932, p 1932 (2021)
Simple Summary NTRK fusion genes are important but not well studied molecular markers in thyroid cancer. Their identification could help improve diagnosis and prognosis, and determine appropriate treatment. The aims of this study were to identify NTR
Autor:
Manfred Schmidt, Arndt Hartmann, Rainer Fietkau, Ulf Lamprecht, Thomas Weissmann, Rolf D. Issels, Lars H. Lindner, Claus Belka, Daniel Zips, Robert Grützmann, Oliver J. Ott, S. Abdel-Rahman, Cihan Gani, Axel Hinke
Publikováno v:
Cancers, Vol 13, Iss 1279, p 1279 (2021)
Cancers
Volume 13
Issue 6
Cancers
Volume 13
Issue 6
Background: To prospectively analyze feasibility and pathological complete response (pCR) rates of neoadjuvant chemoradiotherapy combined with regional hyperthermia (RHT) in patients with locally advanced (LARC) or recurrent (LRRC) rectal cancer. Met
Autor:
Antony W. Burgess, Michael McCullough, Oliver M. Sieber, Kendrick Koo, Tim A. Iseli, Christopher Angel, David Wiesenfeld, Dmitri Mouradov
Publikováno v:
Cancers
Volume 13
Issue 5
Cancers, Vol 13, Iss 1029, p 1029 (2021)
Volume 13
Issue 5
Cancers, Vol 13, Iss 1029, p 1029 (2021)
Molecular alterations in 176 patients with oral squamous cell carcinomas (OSCC) were evaluated to delineate differences in non-smoking non-drinking (NSND) patients. Somatic mutations and DNA copy number variations (CNVs) in a 68-gene panel and human
Autor:
Cameron Snell, Asmerom T. Sengal, Deborah Smith, Rebecca Rogers, Elizabeth D. Williams, Pamela M. Pollock
Publikováno v:
Cancers
Volume 13
Issue 7
Cancers, Vol 13, Iss 1703, p 1703 (2021)
Volume 13
Issue 7
Cancers, Vol 13, Iss 1703, p 1703 (2021)
Women with atypical hyperplasia (AH) or well-differentiated early-stage endometrioid endometrial carcinoma (EEC) who wish to retain fertility and/or with comorbidities precluding surgery, are treated with progestin. Clinically approved predictive bio
Publikováno v:
Cancers
Volume 13
Issue 3
Cancers, Vol 13, Iss 372, p 372 (2021)
Volume 13
Issue 3
Cancers, Vol 13, Iss 372, p 372 (2021)
Simple Summary Real-time ex vivo drug testing tailors individual therapeutics based on predicted drug responses. Most technologies to date rely on conventional drug screening that provides low confidence data. Here, we present high-content analysis-b
Autor:
Alfonso De Stefano, Antonella Petrillo, Luca Brunese, Vincenza Granata, Roberta Fusco, Alessandro Ottaiano, Antonio Avallone, Francesco Izzo, Carolina Sbordone
Publikováno v:
Cancers, Vol 13, Iss 453, p 453 (2021)
Cancers
Volume 13
Issue 3
Cancers
Volume 13
Issue 3
Purpose: To assess the association of RAS mutation status and radiomics-derived data by Contrast Enhanced-Magnetic Resonance Imaging (CE-MRI) in liver metastases. Materials and Methods: 76 patients (36 women and 40 men
59 years of mean age and 3
59 years of mean age and 3
Autor:
Hans C. Ludwig, Anna K. Hell, Katja A Lüders, Christof M. Kramm, Hans Christoph Bock, Ingrid Kühnle, Konstantinos Tsaknakis, Lena Braunschweig, Heiko M. Lorenz
Publikováno v:
Cancers
Volume 12
Issue 12
Cancers, Vol 12, Iss 3555, p 3555 (2020)
Volume 12
Issue 12
Cancers, Vol 12, Iss 3555, p 3555 (2020)
Childhood tumors of the central nervous system (CNS) and other entities affecting the spine are rare. Treatment options vary from surgical biopsy to partial, subtotal, and total resection, to radiation, to chemotherapy. The aim of this study is to in
Autor:
Rachel Sharkey, Roxana Reyes, Josep Tabernero, Joanne Evans, Daniela Ferrante, Joan Brunet, Andrea Patriarca, Mattia Bellan, Gianluca Gaidano, Isabel Garcia-Fructuoso, Anna Carbó, Christopher C T Sng, Alessandra Gennari, Mark Bower, Sarah Benafif, Alessia Dalla Pria, Lorenza Scotti, Elia Seguí, Riccardo Bruna, Francesca D'Avanzo, Aleix Prat, Claudia Andrea Cruz, Diego Ottaviani, Gianpiero Rizzo, Yien Ning Sophia Wong, Meritxell Mollà, Mario Pirisi, Pier Paolo Sainaghi, Thomas Newsom-Davis, Isabel Ruiz-Camps, Gian Carlo Avanzi, Myria Galazi, Javier Marco-Hernández, David J. Pinato, Federica Biello, Alvin J.X. Lee, Neha Chopra, Juan Aguilar-Company, Carme Carmona, Luigi Mario Castello
Publikováno v:
Cancers
Volume 12
Issue 7
Scientia
Cancers, Vol 12, Iss 1841, p 1841 (2020)
Volume 12
Issue 7
Scientia
Cancers, Vol 12, Iss 1841, p 1841 (2020)
We describe the outcomes in cancer patients during the initial outbreak of the COVID-19 in Europe from the retrospective, multi-center observational OnCovid study. We identified 204 cancer patients from eight centers in the United Kingdom, Italy, and
Autor:
János Kappelmayer, Katalin Gyurina, Ágnes Vojczek, Lilla Gyorgyi Tiszlavicz, Gábor T. Kovács, Karin Nebral, Angela Schumich, Csongor Kiss, A Kolenova, Łukasz Sędek, Pál Jáksó, Andishe Attarbaschi, Oskar A. Haas, Attila Nagy, Zsuzsanna Hevessy, Peter Svec, Gábor Barna, Eszter Szánthó, Bettina Kárai, Michael Dworzak, István Szegedi, Tomasz Szczepański, Anikó Ujfalusi, Jerzy Kowalczyk, Judit Müller, Réka Simon
Publikováno v:
Cancers
Cancers, Vol 12, Iss 2264, p 2264 (2020)
Volume 12
Issue 8
Cancers, Vol 12, Iss 2264, p 2264 (2020)
Volume 12
Issue 8
Background: Based on previous retrospective results, we investigated the association of coagulation FXIII subunit A (FXIII-A) expression pattern on survival and correlations with known prognostic factors of B-cell progenitor (BCP) childhood acute lym
Autor:
Maximilian Schulze-Hagen, Christiane K. Kuhl, Philipp Bruners, Daniel Heise, Peter Isfort, I. Amygdalos, Lea Hitpass, Ulf P. Neumann, Federico Pedersoli, Florian Ulmer, Markus Zimmermann
Publikováno v:
Cancers
Cancers, Vol 12, Iss 1638, p 1638 (2020)
Volume 12
Issue 6
Cancers, Vol 12, Iss 1638, p 1638 (2020)
Volume 12
Issue 6
The aim of this study was to identify prognostic factors affecting intrahepatic progression-free survival (ihPFS) and overall survival (OS) in patients with colorectal cancer liver metastases (CRCLM) undergoing portal vein embolization (PVE) and subs